The human samples used in this study were acquired from metastatic lesions surgically removed from cutaneous CM patients that did not underwent prior therapy with BRAF inhibitors who were referred to the National Cancer Institute of Aviano (Italy), as described in “Altomonte M et al. The gene discussed is BRAF; the disease is cutaneous mastocytosis.